Co-Authors
This is a "connection" page, showing publications co-authored by MICHAEL SCHEURER and RITSUKO KOMAKI.
Connection Strength
0.216
-
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac152.
Score: 0.216
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.